Diagnosis of aspergillus niger peritonitis in a peritoneal dialysis patient by peritoneal galactomannan and β-d-glucan detection

Peritoneal Dialysis International

Volumn 33, Issue 2, 2013, Pages 216-218

  Ates, O ^a   Metan, G ^a   Dundar, T ^a   Kiziltepe, M ^a   Kocyigit, I ^a   Unal, A ^a   Sipahioglu, M ^a   Oymak, O ^a   Tokgoz, B ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B; BETA DEXTRO GLUCAN; CEFAZOLIN; GALACTOMANNAN; GLUCAN; UNCLASSIFIED DRUG; VANCOMYCIN;

ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ADULT; ANTIBIOTIC THERAPY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS NIGER PERITONITIS; CASE REPORT; CATHETER REMOVAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIARRHEA; FEMALE; FUNGUS CULTURE; FUNGUS ISOLATION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LEUKOCYTE COUNT; NAUSEA; NEPHROLITHIASIS; PERITONEAL CATHETER; PERITONITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; VOMITING;

ADULT; ASPERGILLOSIS; ASPERGILLUS NIGER; BETA-GLUCANS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MANNANS; PERITONEAL DIALYSIS; PERITONITIS;

EID: 84878980640     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2012.00042     Document Type: Article

References (11)

1. Bren A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 1998; 17:839-43.
2. Wang AY, Yu AW, Li PK, Lam PK, Leung CB, Lai KN, et al. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis 2000; 36:1183-92.
3. Bibashi E, Papagianni A, Kelesidis A, Antoniadou R, Papadimitriou M. Peritonitis due to Aspergillus niger in a patient on continuous ambulatory peritoneal dialysis shortly after kidney graft rejection. Nephrol Dial Transplant 1993; 8:185-7.
4. Sridhar R, Thornley-Brown D, Kant KS. Peritonitis due to Aspergillus niger: diagnostic importance of peritoneal eosinophilia. Perit Dial Int 1990; 10:100-1.
5. Rodriguez-Tudela JL, Barros C, Aguado JM, Gomez-Garcés JL, Velo M, de Arriba G. Aspergillus niger peritonitis. Nephrol Dial Transplant 1988; 3:232.
6. Hsu JL, Ruoss SJ, Bower ND, Lin M, Holodniy M, Stevens DA. Diagnosing invasive fungal disease in critically ill patients. Crit Rev Microbiol 2011; 37:277-312.
7. Petraitiene R, Petraitis V, Groll AH, Sein T, Piscitelli S, Candelario M, et al. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia. Antimicrob Agents Chemother 2001; 45:857-69.
8. Maertens J, Theunissen K, Verbeken E, Lagrou K, Verhaegen J, Boogaerts M, et al. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004; 126:852-60.
9. Preuner S, Lion T. Towards molecular diagnostics of invasive fungal infections. Expert Rev Mol Diagn 2009; 9:397-401.
10. Associates of Cape Cod. Fungitell Assay [Web page]. East Falmouth, MA: Associates of Cape Cod; n.d. [Available at: http://www.acciusa.com/clinical/fungitell/index.html; accessed 28 August 2011]
11. Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H, et al. Plasma (1→3)-β-d-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345:17-20.